|

Oral Anticoagulant plus background antiplatelet therapy Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Icahn School of Medicine at Mount Sinai1

Indications

  • Heart Disease1
  • Atrial Fibrillation1
  • Bleeding1
  • Stroke1

Little Rock, Arkansas1 trial

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

CHI St. Vincent, Arkansas

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.